Zobrazeno 1 - 10
of 20
pro vyhledávání: '"Katherine M. Eichinger"'
Autor:
Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola, David H. Chi, Timothy N. Perkins, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Activated lung ILC2s produce large quantities of IL-5 and IL-13 that contribute to eosinophilic inflammation and mucus production following respiratory syncytial virus infection (RSV). The current understanding of ILC2 activation during RSV infection
Externí odkaz:
https://doaj.org/article/0a90671dc3314c568903c089a58855ff
Autor:
Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Sonal V. Gidwani, Devarshi Brahmbhatt, Mark A. Yondola, Timothy N. Perkins, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
Respiratory syncytial virus (RSV) is the leading cause of childhood hospitalizations due to bronchiolitis in children under 5 years of age. Moreover, severe RSV disease requiring hospitalization is associated with the subsequent development of wheezi
Externí odkaz:
https://doaj.org/article/728492b18d2242a48eafb2a24939ac4e
Autor:
Katherine M. Eichinger, Jessica L. Kosanovich, Timothy N. Perkins, Tim D. Oury, Nikolai Petrovsky, Christopher P. Marshall, Mark A. Yondola, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 13 (2022)
Respiratory syncytial virus (RSV) remains the most common cause of lower respiratory tract infections in children worldwide. Development of a vaccine has been hindered due the risk of enhanced respiratory disease (ERD) following natural RSV exposure
Externí odkaz:
https://doaj.org/article/116afe5507074f2588c9400d0bb46bac
Autor:
Katherine M. Eichinger, Jessica L. Kosanovich, Madeline Lipp, Kerry M. Empey, Nikolai Petrovsky
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 9 (2021)
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vacci
Externí odkaz:
https://doaj.org/article/c0c92066f567490691ceb9a63d2dc711
Autor:
Katherine M. Eichinger, Jessica L. Kosanovich, Sonal V. Gidwani, Aaron Zomback, Madeline A. Lipp, Timothy N. Perkins, Tim D. Oury, Nikolai Petrovsky, Christopher P. Marshall, Mark A. Yondola, Kerry M. Empey
Publikováno v:
Frontiers in Immunology, Vol 11 (2020)
Respiratory syncytial virus (RSV) remains the most common cause of lower respiratory tract infections in children worldwide. Development of a vaccine has been hindered by the risk of developing enhanced respiratory disease (ERD) upon natural exposure
Externí odkaz:
https://doaj.org/article/dc7b75cccbe24d529c8492eb0339ddec
Autor:
Katherine M. Eichinger, Kerry M. Empey
Publikováno v:
Data in Brief, Vol 14, Iss C, Pp 272-277 (2017)
The data presented here are related to the research article entitled “Age predicts cytokine kinetics and innate immune cell activation following intranasal delivery of IFNγ and GM-CSF in a mouse model of RSV infection” (Eichinger et al., 2017) [
Externí odkaz:
https://doaj.org/article/e3c1090768284960bd296b7fd9110ae7
Autor:
Nikolai Petrovsky, Christopher Patrick Marshall, Mark Andrew Yondola, Katherine M. Eichinger, Madeline A. Lipp, Kerry M. Empey, Jessica L. Kosanovich, Timothy N. Perkins
Publikováno v:
Vaccine
Respiratory syncytial virus (RSV) commonly causes severe respiratory tract infections in infants, peaking between 2 and 6 months of age; an age at which direct vaccination is unlikely to be effective. Maternal immunization can deliver high levels of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::370c6c13702d5024b55dfc0f333c4295
https://doi.org/10.1016/j.vaccine.2020.10.065
https://doi.org/10.1016/j.vaccine.2020.10.065
Publikováno v:
Expert Review of Clinical Immunology
Introduction: Neonates are less responsive to vaccines than adults, making it harder to protect newborns against infection. Neonatal differences in antigen-presenting cell, B and T cell function, all likely contribute. A key question is whether novel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ed7bad7928c87f8dddc28d1d5974312
http://europepmc.org/articles/PMC6678067
http://europepmc.org/articles/PMC6678067
Autor:
Nikolai Petrovsky, Jessica L. Kosanovich, Katherine M. Eichinger, Kerry M. Empey, Madeline A. Lipp
Publikováno v:
Therapeutic Advances in Vaccines and Immunotherapy, Vol 9 (2021)
Therapeutic Advances in Vaccines and Immunotherapy
Therapeutic Advances in Vaccines and Immunotherapy
Respiratory syncytial virus (RSV) is the leading cause of lower respiratory tract infections in children worldwide, with the most severe disease occurring in very young infants. Despite half a century of research there still are no licensed RSV vacci
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c1d524746621a4270b03c35a33e9e3ca
https://doaj.org/article/c0c92066f567490691ceb9a63d2dc711
https://doaj.org/article/c0c92066f567490691ceb9a63d2dc711
Autor:
Timothy N. Perkins, Jessica L. Kosanovich, Katherine M. Eichinger, Madeline A. Lipp, Kerry M. Empey, Mark Andrew Yondola
Publikováno v:
Vaccine
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections among infants with most infections occurring in the first year of life. Multiple RSV exposures are required for children to mount adult-like immune responses.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::563fbc197c7292a51aeee713962c58b5
https://europepmc.org/articles/PMC7540734/
https://europepmc.org/articles/PMC7540734/
